Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. It delivers drugs into body compartments, such as the joint without any of the common issues with body compartment injections, such as systemic exposure. The firm focuses on arthritis, diabetic macular edema, and chronic pain programs. The company was founded by James A. Helliwell, John Salvatore Montalbano and Amanda Malone on May 12, 2011 and is headquartered in Victoria, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Eupraxia Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Eupraxia Pharmaceuticals Inc market cap is $191.66M.
What is the 52-week high for Eupraxia Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Eupraxia Pharmaceuticals Inc 52 week high is $6.20 as of September 17, 2025.
What is the 52-week low for Eupraxia Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Eupraxia Pharmaceuticals Inc 52 week low is $2.20 as of September 17, 2025.
What is Eupraxia Pharmaceuticals Inc stock price today?
Eupraxia Pharmaceuticals Inc stock price today is $5.33.
What was Eupraxia Pharmaceuticals Inc stock price yesterday?
Eupraxia Pharmaceuticals Inc stock price yesterday was $5.30.
What is the PE ratio of Eupraxia Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Eupraxia Pharmaceuticals Inc’s P/E ratio is -6.30.
What is the Price-to-Book ratio of Eupraxia Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Eupraxia Pharmaceuticals Inc P/B ratio is -20.9463.
What is the 50-day moving average of Eupraxia Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Eupraxia Pharmaceuticals Inc 50-day moving average is $5.36.
